Lehigh Valley Topper Cancer Institute is offering tumour-infiltrating lymphocyte (TIL) therapy for advanced skin cancer patients, harnessing the patient’s own immune cells to improve outcomes. #TILTherapy #SkinCancer #Immunotherapy #TCSC
www.lvhn.org/news/innovat...
Today, Rusty's tumors are shrinking, and he’s back to doing what he loves. His story is a powerful reminder of how cutting-edge care and unwavering spirit can change lives.
#MelanomaAwareness #TILTherapy #PatientStory #MedicalInnovation
SCI leader @funchainmd.bsky.social & others review treatment strategies for #MetastaticMelanoma: BRAF/MEK inhibitors improve survival; #TILtherapy shows 30% durable response; novel TCR-T & CD3 bispecifics emerging; ICI viable even with irAEs, age, or transplant history.
Thea Malile presented on #TILtherapy in-service education yesterday in Poster Session 3 at #ONS50. View her abstract: ons.confex.com/ons/2025/meeti…
@SmilowCancer @YaleMed @YNHH
Breakthrough! A new NIH trial shows combo immunotherapy (TIL therapy) shrank metastatic GI cancers—including #colon, #rectum, #pancreas & bile duct tumours. Game-changing progress! #TCSC #CancerResearch #immunotherapy #TILtherapy #gicancer #NIH #oncology
www.nih.gov/news-events/...
📢 New landmark research out today on #TILTherapy for GI cancers
❓Can neoantigen-specific tumor-infiltrating lymphocytes (TILs) improve #immunotherapy for gastrointestinal cancers?
Ten months after treatment with selected TIL therapy and pembrolizumab, a patient with rectal cancer had substantial shrinkage of multiple liver metastases (left scans, circled in red).
Read more here 👉 bit.ly/Blog-NIH-GI-...
#TILtherapy #pembrolizumab #colorectalcancer
Dr. Kelly Olino highlights the importance of balancing risk v. reward in patient selection for #TILtherapy based on experience with #melanoma and future directions to improve the treatment platform. #SSO2025
@socsurgonc.bsky.social @yaleschoolofmed.bsky.social
Welcome to San Diego Dr. Lim, we’re thrilled to have you at #SITCSpringScientific25!
This program is packed with cutting-edge research and insights from leaders in the field!
#TILtherapy #CellTherapy #CanSky
Practical considerations for best practices to apply TIL therapy - Marco Donia
@bmj.com
oncodaily.com/blog/marco-d...
#BMJJournals #Cancer #JournalForImmunotherpyofCancer #SITC #OncoDaily #Oncology #TILTherapy #SocietyForImmunotherapyOfCancer #Medicine #Health
Let’s go! 🙌🏼🙌🏼🙌🏼
#CellTherapy
#TILTherapy
Welcome to 🦋🦋🦋
@drbetofmdphd.bsky.social
@sklobuch.bsky.social
What an honour hosting John Haanen #nki today #NCCS - talking all #celltherapy #TILtherapy & visiting our national GMP facility 👩🏻🔬
And a fascinating talk on myeloids in lung by @charlesswanton.bsky.social ☺️
#ESMOAsia24
The results from IOV-COM-202 cohort 1a vs previous Iovance TIL trials in checkpoint refractory melanoma patients plus the NCI Surgery Branch's dataset definitely bring into question where in the sequence of therapies TIL ACT should sit. #TILTherapy
Fascinating how this was 40 years ago! Truly inspiring and we will be delivering #celltherapy to our patients here in #Singapore too!
#TILTherapy
#cancerimmunotherapy
It's that time again when we all crowd along the bay and take a morning run/walk for #CancerResearch. Looking forward to another year of #MilesforMoffitt with our #TILTherapy team, the #TurTILs. MilesforMoffitt.com
